Published in Primary Care

The Ultimate Guide to Solutions from Topcon Healthcare, Inc.

This post is sponsored by Topcon Healthcare
17 min read

Discover how Topcon Healthcare improves diagnostic accuracy, facilitates connected care, and promotes scalable growth in optometry and ophthalmology practices.

The Ultimate Guide to Solutions from Topcon Healthcare, Inc.
For more than 90 years, Topcon Healthcare has delivered innovations designed to help eye care professionals provide the highest quality care and meet the evolving needs and expectations of their patients. That commitment continues today, as clinicians face increasing pressure to manage growing patient volumes, diagnose complex diseases, and communicate clearly with patients while maintaining efficient workflows. Patients expect a seamless experience that is supported by advanced technology, straightforward explanations, and confidence in their care team. Looking ahead, the emergence of AI and oculomics (the science of leveraging ocular data to identify signs of systemic and neurological conditions) will soon place eye care professionals at the center of chronic disease management, working collaboratively with other healthcare providers.
By combining automated robotic technologies, connected cloud-based platforms, and AI-based applications, Topcon Healthcare helps practices meet these challenges with greater clinical confidence and streamlined workflows that elevate the patient experience across the continuum of care. In these modern times, patients are no longer surprised by high tech, they expect it.
As a direct sales and service organization, Topcon Healthcare supports practices throughout the entire lifecycle. From technology selection and installation to training and ongoing service, this direct model helps practices standardize operations, minimize downtime, and maintain consistent performance across locations as their clinical needs evolve.

Healthcare from the Eye

Topcon Healthcare’s strategy for addressing the global healthcare challenges of rising costs and limited access is Healthcare from the Eye. This approach delivers oculomics through a connected care network, leveraging ocular imaging, functional assessments, and longitudinal data to identify health risks early in the disease process for both ocular and systemic conditions.
Earlier detection and the connected network enable more effective identification and management of patients with costly, chronic diseases.
The Healthcare from the Eye network runs on Harmony®, a cloud-based, vendor-inclusive clinical data and workflow management platform that serves as the connective tissue of Topcon Healthcare’s ecosystem. Harmony centralizes multimodal imaging and clinical data in a secure, browser-based environment. Clinicians can review information remotely, customize views to match their preferences, and share insights seamlessly across providers and locations (Figure 1).
Figure 1. Harmony with Split View
Figure 1. Harmony with Split View

From Oculomics to Real-World Impact

Building on this connected foundation, oculomics is already influencing clinical approaches to screening and disease management. Data from fundus photos and retinal OCT have been shown to correlate with cardiovascular, metabolic, and neurologic conditions. Applying proven AI models to ocular data can provide actionable insights that integrate directly into clinical decision-making. The Topcon Healthcare AI application ecosystem already includes BioAge wellness assessment and diabetic retinopathy screening. In parallel, healthcare-AI experts are developing new models for early detection of conditions such as cardiovascular disease, chronic kidney disease, Alzheimer’s disease, traumatic brain injury, and pre-eclampsia.
Dr. Kannarr notes that patient communication plays a critical role in this process.

Advancing Retina Care Through Connected and Robotic Imaging

Effective retinal disease management requires confident structural and vascular assessment, especially as incidents of diabetic retinopathy and age-related macular degeneration continue to rise. Clinicians need imaging solutions that provide comprehensive diagnostic insight while enabling efficient, repeatable workflows.
Multimodal imaging platforms, such as Maestro2 OCT® and Triton, combine true-color fundus photography, OCT, and OCT angiography together into a single workflow (Figure 2). This integration reduces patient movement between devices and shortens exam times, improving both efficiency and patient comfort. Maestro2 OCT supports automated alignment and one-touch acquisition, while Triton’s swept-source technology enables deep tissue penetration, making diagnosis possible even in challenging cases such as patients with dense cataracts.
Figure 2. OCTA acquisition using Maestro2
Figure 2. OCTA acquisition using Maestro2
Understanding how disease and treatment impact vision remains central to retina care, and standardizing this functional measurement objectively is foundational to leveraging data for AI-driven clinical insights. The KR-800S captures a reproducible, objective baseline visual acuity and refraction in the workup room before the provider exam, eliminating the subjective variability inherent in manual visual acuity testing. This standardized approach ensures that vision data is comparable across visits, providers, sites, and populations. This is a critical requirement for aggregating datasets and training reliable AI models. By establishing consistent, automated measurements of where a patient's vision "starts" at each visit, the KR-800S helps practices track whether treatment is translating into functional improvement with precision.
When paired with structural findings from multimodal imaging, a complete functional-structural dataset is created that can reveal patterns invisible in either measure alone. With automated alignment, focus, and standardized data capture, the KR-800S reduces operator variability and ensures consistent measurement quality, essential advantages not only for monitoring chronic disease progression in individual patients but for building the high-quality, longitudinal datasets required to power AI algorithms and deliver scalable, data-driven insights across entire patient populations.
Fundus photography remains a cornerstone of retinal evaluation and screening. Slit scan non-mydriatic cameras, such as the NW500, are a game changer for efficient diabetic retinopathy screening and routine eye exams, as they can capture high-quality images even in patients with small pupils or media opacities. For more complex retinal cases, mydriatic systems like the TRC-50DX provide advanced imaging, including angiographic capabilities. When reviewed longitudinally within Harmony, these imaging modalities support more informed decision-making and collaborative care.

Integrating Structure, Function, and Longitudinal Insight in Glaucoma

Glaucoma management relies on the ability to detect change early and track progression confidently over time. Structural imaging, functional testing, and intraocular pressure measurements each provide important information, but their true value emerges when these data are evaluated together rather than in isolation.
Structural assessment using OCT remains foundational in glaucoma care. Imaging platforms such as Maestro2 support detailed evaluation of the retinal nerve fiber layer, ganglion cell layer, and optic nerve head. Robotic acquisition, automated alignment, and a single scan that covers all essential parameters help ensure repeatable scans across visits, minimizing variability and supporting more reliable trend analysis.
Functional testing complements these structural insights, and modern visual field solutions address workflow challenges in different ways. TEMPO™ (Figure 3), a table-top perimeter, reimagines the traditional perimetry experience by enabling faster binocular testing in ambient lighting conditions. This eliminates the need for dark room testing environments while speeding up testing time, reducing patient fatigue, and streamlining the exam process.
Figure 3. Tempo™ with Single Field Analysis
Figure 3. Tempo with Single Field Analysis
For practices seeking to expand testing capacity affordably, Inspire® offers a medical grade wearable solution that allows multiple devices to be deployed across the practice. By enabling visual field testing beyond dedicated diagnostic rooms, Inspire provides the flexibility to test patients in various locations while maintaining clinical reliability. Both solutions provide results that correlate closely with traditional perimetry, ensuring diagnostic confidence while improving patient comfort and practice efficiency.
When structural and functional findings align, clinicians gain greater diagnostic clarity in both diagnosis and treatment decisions. Synthesizing these data longitudinally is increasingly important, particularly as patients are followed over many years. Harmony brings OCT, visual fields, and ancillary data into a single, customizable view, enabling clinicians to assess progression trends quickly and consistently.
Accurate pre-test measurements, including intraocular pressure and corneal thickness, captured efficiently and objectively in the exam lane, further support this integrated approach and help guide earlier intervention.

Supporting Myopia Management Earlier in the Patient Journey

As the prevalence of myopia continues to rise worldwide, particularly among pediatric and adolescent populations, myopia management has become an increasingly important component of the comprehensive eye exam. With therapies becoming readily available and more children presenting earlier with rapid progression, early identification, treatment, and longitudinal monitoring are essential. This reality requires objective, repeatable measurements that are easy to communicate to families. Rather than relying on refractive error alone, many clinicians now emphasize axial length as a key indicator of myopia progression.
Technologies such as MYAH® support this approach by combining precise axial length measurement and corneal assessment on a single platform, making it easier to track progression over time and assess treatment effectiveness (Figure 4). Additional myopia analytics are now integrated into MYAH, elevating it to a myopia management platform.
Figure 4. MYAH® RX/AL Trends
Figure 4. MYAH® RX/AL Trends
By grounding myopia management in objective data, practices elevate both clinical outcomes and the overall patient experience while reinforcing the importance of long-term follow-up.

Reframing Dry Eye as a Lane-Based Workflow

Dry eye disease is no longer evaluated solely at the slit lamp. In modern practices, effective dry eye management begins in pre-testing, where objective data can be gathered efficiently before the clinician enters the room.
Positioned within the pre-test room, the TERA Dry Eye Imager™ allows staff to capture critical information on tear film stability and meibomian gland structure (Figure 5) early in the patient journey. Noninvasive tear breakup time and infrared meibography provide a quantifiable baseline, reframing dry eye as a measurable condition rather than a subjective complaint.
Figure 5. Meibography with TERA Dry Eye Imager
Figure 5. Meibography with TERA Dry Eye Imager
Automation and robotic alignment further support this workflow, ensuring consistent data capture while reducing technician burden.

Advancing Anterior Segment Evaluation and Patient Education

Once dry eye or ocular surface disease is identified, detailed anterior segment evaluation becomes essential. Digital-ready slit lamps such as the SL-D701, paired with the DC-4 digital camera, allow clinicians to document lid margins, tear film quality, and corneal findings with clarity and consistency (Figure 6).
Figure 6. Image captured using an SL-D701 with a DC-4 Digital Camera attachment
Figure 6. Image captured using an SL-D701 with a DC-4 Digital Camera attachment
These imaging tools integrate seamlessly into the lane, supporting diagnosis, documentation, and education to enhance the care experience.

Cataract Evaluation and Preoperative Optimization

Successful cataract care and surgical outcomes now depend on a comprehensive understanding of the patient’s visual system, ocular surface health, and biometric accuracy, all within an efficient workflow.
During cataract evaluation, early screening measurements such as intraocular pressure and corneal thickness help inform surgical planning and risk assessment. When captured efficiently and objectively during pre-testing, a single, integrated workflow - including refractometry, keratometry, tonometry, and pachymetry - using the OMNIA, complements advanced biometry and ocular surface evaluation without adding complexity to the visit.
Additional screening tools, such as the KR-800S, Auto Kerato-Refractometer, support cataract evaluation by combining objective refractometry with glare testing and visual acuity assessment. These measurements help clinicians better understand functional vision, identify the impact of media opacity, and support conversations around surgical timing and expectations, without adding complexity to the exam.
Advanced biometry solutions such as the Aladdin Biometer remain central to cataract planning, integrating axial length, corneal measurements, anterior chamber depth, and advanced IOL calculation formulas to support a wide range of cases. With 9-in-1 exams, Aladdin is optimizing the clinical workflow for cataract patients by acquiring all necessary measurements in less than five seconds (Figure 7).
Figure 7. Cataract Workstation featuring the KR-800S and Aladdin
Figure 7. Cataract Workstation featuring the KR-800S and Aladdin
Equally important is information about the ocular surface. Technologies such as TERA Dry Eye Imager provide objective metrics that help clinicians identify dry eye prior to surgery, thereby improving outcomes.

The Digital Lane as the Foundation of Patient Experience

Bringing these technologies together requires a physical environment designed for efficiency and ergonomics. Digital exam lane configurations (Figure 8), customized for each practice’s needs, allow clinicians to move smoothly from screening to diagnosis to education within a single visit.
Figure 8. Exam Lane Configuration
Figure 8. Exam Lane Configuration
A key element of the modern exam lane is automated refraction, where consistency and patient comfort are just as important as speed. Automated phoropters such as the CV-5000 support a more streamlined refraction experience by reducing manual adjustments and standardizing testing conditions. By automating lens changes and enabling smooth transitions between steps, clinicians can maintain focus on the patient rather than the equipment.
In some practice settings, the digital exam lane can also extend beyond the physical exam room. Remote refraction capabilities demonstrated with RDx® allow clinicians to support refraction workflows and diagnostic screening from a different location, helping practices maintain continuity of care when staffing resources are limited or care needs extend across multiple sites. By preserving the same standardized refraction experience while adding flexibility, remote refraction supports access to care without compromising clinical oversight. RDx and Harmony together provide a comprehensive tele-eyecare solution for providers and patients.

Looking Toward the Practice of the Future

Across disease states, robotics, automation, and connected data management are reshaping eye care practices. By reducing variability at the point of capture and making patient data easier to interpret and share, these technologies allow clinicians to focus less on process and more on patient care.
The common thread is integrated systems that support better decisions, more consistent care, and stronger patient relationships. Updated technology is becoming even more critical as oculomics becomes common practice and eye care professionals begin to play a greater and more integrated role in patient care.
This approach reflects Topcon Healthcare’s focus on providing technology solutions that support clinicians while keeping care human.
Eyes On Eyecare Editorial Team
About Eyes On Eyecare Editorial Team

Led by Editor-in-Chief Eleanor Gold, PhD, Eyes On Eyecare is a digital publication that provides clinical and career education to the young generation of optometrists and ophthalmologists. We work with eyecare professionals to create compelling, educational content available for free to all those in the eyecare industry. To learn more about our team, values, and other projects, visit our About page.

Eyes On Eyecare Editorial Team
Glenda Aleman, OD
About Glenda Aleman, OD

Dr. Aleman-Moheeputh graduated from Nova Southeastern University with a Bachelor of Science degree in Vision Science. She went on to receive her Doctor of Optometry degree from NSU’s College of Optometry in which she led the class of 2017 as Vice President. She serves as the President of the American Academy of Myopia Control and Orthokeratology (AAOMC) South Florida Chapter. She also holds the position of lead ambassador for the Optometry Divas Miami Chapter, and acts on the Chair Advisory committee of the Broward College Opticianry program.

Presently, Dr. Aleman-Moheeputh is an acting optometrist and business owner, managing her own private practice, iSmart Vision Care. In her mission to stop the myopia epidemic, Dr. Aleman-Moheeputh has recently launched her new venture, OK Love designed to educate and consult fellow optometrist colleagues about myopia control treatments

Glenda Aleman, OD
Shane Kannarr, OD
About Shane Kannarr, OD

Shane R. Kannarr, OD, grew up in southeast Kansas and graduated from Humboldt High School. He attended Pittsburg State University (PSU), where he received a degree in biology education. During his time at PSU, he met his wife, Amy Askins Kannarr. He earned his Doctorate of Optometry at the University of Missouri-St. Louis. Upon graduation, he practiced in southwest Missouri and Kansas City before returning to Pittsburg. He has practiced in Pittsburg since 2006 and opened Kannarr Eye Care in 2009. Dr. Kannarr is currently on staff at both Via Christi and Girard Medical Center. He treats all types of medical conditions relating to the eye, with specific interests in dry eyes, glaucoma, and diabetic eye disease. Dr. Kannarr has recently added low vision services to his practice to meet the community's needs.

Dr. Kannarr is active in many aspects of optometry. He is very involved in research and is at the forefront of contact lens technology, with experience in toric, bifocal, and contact lenses for dry eyes. His research in contacts and pharmaceuticals is ongoing through extensive studies and state-of-the-art technology. Dr. Kannarr lectures across the country in the areas of ocular disease, ophthalmic medication, contact lenses, and practice management. He enjoys staying at the forefront of eye care and sharing information with colleagues.

Shane Kannarr, OD
Eric Donnenfeld, MD
About Eric Donnenfeld, MD

Eric Donnenfeld, MD is one of the ophthalmology industry's leading experts. With a career spanning over 20 years, he has helped to revolutionize the field. He is highly passionate about ophthalmology, his career, and helping his patients.

Eric Donnenfeld, MD
Ike Ahmed, MD
About Ike Ahmed, MD

Dr. Ahmed has become world renowned for his skills and groundbreaking work in the diagnosis and surgical treatment of highly complex eye diseases including glaucoma and surgical complications. He is recognized as being one of the most experienced complex eye surgeons in the world and has trained numerous surgeons in innovative surgical techniques. Furthermore, he has been at the leading edge of novel treatments for glaucoma, cataract and lens implant surgery. Patients are referred to him locally, nationally, and from around the world. He has been invited to perform surgery in 4 continents across the globe. Dr. Ahmed has a keen interest in the development of advanced microsurgical devices and techniques in glaucoma surgery and complicated cataract extraction, and is actively involved in research and medical education at a national and international level. He has received research grants to study glaucoma medications, glaucoma laser and surgical devices/techniques, angle closure glaucoma, anterior segment and retinal/optic nerve imaging in glaucoma, cataract surgical techniques and devices, and intraocular lens designs. Dr. Ahmed has designed innovative glaucoma diamond scalpels for surgery, microsurgical instrumentation, and devices, implants, and techniques for the management of the dislocated cataract, iris reconstruction, and glaucoma implant devices. He has done pioneering work in innovative glaucoma surgery, developing and coining the term “Micro-Invasive Glaucoma Surgery (MIGS)” as a new genre of surgical approaches and devices. He also performed the first laser cataract surgery in Canada. As a result of his innovative expertise, Dr. Ahmed has been asked to consult for a variety of companies and manufacturers, especially pertaining to the development of new devices and technologies.

Ike Ahmed, MD
Kerry Salsberg, OD
About Kerry Salsberg, OD

Dr. Kerry Salsberg earned his Doctorate of Optometry from the University Of Waterloo. He was awarded the T.T. Beattie Award for Orthoptics and Visual Training and is a proud member of the Ontario Association of Optometrists and Regional Administrator of VisionSource Canada. Born and raised in Toronto, Dr. Kerry Salsberg was exposed to Optometry by his father, Dr. Stan Salsberg, a Doctor of Optometry, who has been in private practice for over 43 years. Dr. Salsberg knew that he wanted to follow in his father’s footsteps and has always been interested in science, technology, healthcare, and business. He has been in practice for 21 years, and his interests include Pediatrics, Dry Eye Disease, and Ocular Nutrition. He is at the forefront of new instrumentation and invests in the latest technology to help in the early diagnosis of eye disease and to optimize visual clarity.

Kerry Salsberg, OD
Rishi Singh, MD
About Rishi Singh, MD

Rishi P. Singh, MD is the Chair of the Department of Ophthalmology at Mass General Brigham, overseeing ophthalmology across Massachusetts Eye and Ear, Massachusetts General Hospital, Brigham and Women’s Hospital, and affiliated sites. He is also a Professor of Ophthalmology at Harvard Medical School.
Previously, Dr. Singh served as Vice President and Chief Medical Officer at Cleveland Clinic Martin Health in Stuart, Florida, and as a staff surgeon at the Cleveland Clinic, where he was also Professor of Ophthalmology at the Cleveland Clinic Lerner College of Medicine in Cleveland, Ohio. He received both his undergraduate degree in medical science and his medical degree from Boston University, completing his internship at Tufts University. Dr. Singh went on to complete his ophthalmology residency at the Massachusetts Eye and Ear Infirmary/Harvard Medical School and a medical and surgical vitreoretinal fellowship at the Cole Eye Institute at the Cleveland Clinic.
Dr. Singh specializes in the management of complex retinal diseases, including diabetic retinopathy, retinal vein occlusions, retinal detachment, and age-related macular degeneration. He has authored over 300 peer-reviewed publications, books, and book chapters and serves as Principal Investigator for numerous national and international clinical trials aimed at improving outcomes for patients with retinal diseases.
He is the founder and past president of the Retina World Congress, chairs some of the largest continuing medical education meetings in retina, and serves on editorial boards and review panels for major ophthalmology journals. His leadership has extended into digital innovation, having helped lead enterprise-wide implementation of clinical technologies including Epic modules, digital informed consent, and patient-facing kiosks.
Dr. Singh has received multiple accolades for his contributions to ophthalmic research and innovation, including the Alpha Omega Alpha Research Award, the American Society of Retina Specialists Young Investigator Award, and the J. Donald Gass Beacon of Sight Award. He also leads The Center for Ophthalmic Bioinformatics, a research initiative focused on leveraging big data and artificial intelligence to advance understanding and treatment of retinal disease.

Rishi Singh, MD